Comparison of a fluorogenic anti-FXa assay with a central laboratory chromogenic anti-FXa assay for measuring LMWH activity in patient plasmas.

@article{Harris2011ComparisonOA,
  title={Comparison of a fluorogenic anti-FXa assay with a central laboratory chromogenic anti-FXa assay for measuring LMWH activity in patient plasmas.},
  author={Leanne F. Harris and Vanessa Castro-L{\'o}pez and Pierre Jenkins and James S O'Donnell and Anthony J. Killard},
  journal={Thrombosis research},
  year={2011},
  volume={128 6},
  pages={e125-9}
}
INTRODUCTION Low molecular weight heparins (LMWHs) are used worldwide for the treatment and prophylaxis of thromboembolic disorders. Routine laboratory tests are not required due to the predictable pharmacokinetics of LMWHs, with the exception of pregnant patients, children, patients with renal failure, morbid obesity, or advanced age. Anti-Factor Xa (anti… CONTINUE READING